Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Total Valuation

Fine Foods & Pharmaceuticals N.T.M. S.p.A. carries a market capitalization of 219.58M, placing it among publicly traded companies globally. Its enterprise value stands at 195.45M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Valuation Ratios

Fine Foods & Pharmaceuticals N.T.M. S.p.A. trades at a trailing price-to-earnings ratio of 28.36.

Enterprise Valuation

On an enterprise value basis, Fine Foods & Pharmaceuticals N.T.M. S.p.A. trades at an EV/EBITDA multiple of 14.67 and an EV/FCF ratio of 3.50. The EV/Sales ratio of 0.79 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.67 provides insight into valuation relative to core operating earnings.

Financial Position

Fine Foods & Pharmaceuticals N.T.M. S.p.A. maintains a current ratio of 5.18, meaning it holds 5.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 167.24, indicating elevated leverage, while an interest coverage ratio of 4.60 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Fine Foods & Pharmaceuticals N.T.M. S.p.A. posts a return on equity of 34.75 and a return on invested capital of 10.11.

Taxes

Over the trailing twelve months, Fine Foods & Pharmaceuticals N.T.M. S.p.A. has paid 2.75M in income taxes, reflecting an effective tax rate of 28.55.

Stock Price Statistics

Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s stock has gained approximately 14.5% over the past 52 weeks. The 50-day moving average sits at 8.76, while the 200-day moving average is 9.36.

Income Statement

Over the trailing twelve months, Fine Foods & Pharmaceuticals N.T.M. S.p.A. generated 247.51M in revenue and converted that into 6.89M in net income, yielding earnings per share of 0.30. EBITDA reached 13.32M, while operating income came in at 13.32M.

Cash Flow

Fine Foods & Pharmaceuticals N.T.M. S.p.A. produced 28.98M in operating cash flow over the past twelve months. After subtracting -24.77M in capital expenditures, free cash flow totaled 4.21M - equivalent to 0.18 per share.

Margins

Fine Foods & Pharmaceuticals N.T.M. S.p.A. operates with a gross margin of 45.04, reflecting its pricing power and cost economics. The operating margin of 5.38 and net profit margin of 2.78 provide insight into operational efficiency.

Dividends & Yields

Scores

Fine Foods & Pharmaceuticals N.T.M. S.p.A. posts an Altman Z-Score of 4.50, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.